Pfizer reports Phase 2 eczema data and moves tilrekimig into later trials
About 63% of patients on the highest dose reached EASI-75 skin clearance at 16 weeks, against 20% on placebo.
Intelligence
The parties
Activity
About 63% of patients on the highest dose reached EASI-75 skin clearance at 16 weeks, against 20% on placebo.
Intelligence
Activity